Chylomicronemia and the Chylomicronemia Syndrome: A Practical Approach to Management

American Journal of Medicine

Volumn 121, Issue 1, 2008, Pages 10-12

  Leaf, David Alexander ^a  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Chylomicronemia; Lipids; Pancreatitis

Indexed keywords

FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; INSULIN; LOVAZA; NICOTINIC ACID; OMEGA 3 FATTY ACID; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ARTICLE; BEDTIME DOSAGE; CHYLOMICRONEMIA; CHYLOMICRONEMIA SYNDROME; DIET; DRUG DOSE TITRATION; HUMAN; HYPERLIPIDEMIA; LIFESTYLE MODIFICATION; METABOLIC DISORDER; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SINGLE DRUG DOSE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; XANTHOMA;

EID: 37649020778     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2007.10.004     Document Type: Note

References (21)

1. Parker F., Bagdade J.D., Odland J.F., and Bierman E.L. Evidenced for the chylomicron origin of lipids accumulating in diabetic eruptive xanthoma: a correlative lipid biochemical, histochemical and electron microscopic study. J Clin Invest 49 (1970) 2172-2187
2. Brunzell J.D., and Bierman E.L. Chylomicronemia syndrome. Med Clin North Am 66 (1982) 455-463
3. Mostaza J.M., Vega G.L., Snell P., and Grundy S.M. Abnormal metabolism of free fatty acids in hypertriglyceridaemic men: apparent insulin resistance of adipose tissue. J Intern Med 243 (1998) 265-274
4. Flegal K.M., Carroll M.D., Ogden C.L., and Johnson C.L. Prevalence and trends in obesity among US adults. JAMA 289 (2003) 76-80
5. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults. JAMA 287 (2002) 356-359
6. Mokdad A.H., Bowman B.A., Ford E.S., et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 286 (2000) 1195-2000
7. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
8. Grundy S.M., Mok H.Y., Zech L., et al. Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia. J Clin Invest 63 (1979) 1274-1283
9. Zavaroni I., Dall'Aglio E., Alpi O., et al. Evidence for an independent relationship between insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 55 (1985) 259-267
10. Leaf D.A., Illingworth D.R., and Connor W.E. Lymphadenopathy associated with severe hypertriglyceridemia. JAMA 264 (1990) 727-728
11. 2max, physical activity, and body fat with chronic exercise: effects on plasma lipids. Med Sci Sports Exerc 29 (1997) 1552
12. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
13. Stalenhoef A.F., deGraaf J., Wittekoek M.E., et al. The effect of concentrated fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity, and oxidizability in patients with hypertriglyceridemia. Atherosclerosis 153 (2000) 129-138
14. Chapman M.J. Fribrates in 2003: therapeutic action in atherogenic dyslipidemia and future perspectives. Atherosclerosis 171 (2003) 1-13
15. Harris W.S. N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65 (1997) 1645S-1654S
16. McKenney J.M., and Sica D. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia. Pharmacotherapy 27 (2007) 715-728
17. Venkata A.R., Gandhi M., Braden R., et al. Effect of combination lipid-modifying therapy on the triglyceride lowering effect of fish oil. Am J Med Sci 333 (2007) 168-172
18. McKenny J. New perspectives on the use of niacin in the treatment of lipid disorders. Arch Intern Med 164 (2004) 697-705
19. Eriksson A., Attuau S., Bonnier M., et al. Short-term effect of metformin on type 2 diabetics. Diabetes Obes Metab 9 (2007) 483-489
20. Betteridge D.J. Effects of pioglitazone on lipid metabolism. Diabetes Obes Metab 9 (2007) 640-647
21. Connor W.E. The dietary treatment of hypertriglyceridemia. Med Clin North Am 66 (1982) 485